Status | Study |
Recruiting |
Study Name: Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area Condition: Zika Virus Infection Date: 2016-12-15 Interventions: Other: Placebo Placebo |
Recruiting |
Study Name: Zika-Vaccine Dose Finding Study Regarding Safety, Immunogenicity and Tolerability Condition: Zika Virus Date: 2016-12-15 Interventions: Biological: MV-ZIKA MV-Zika va |
Not yet recruiting |
Study Name: Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil® Condition: Dengue Fever Dengue Hemorrhagic Fever Human Papillomavirus Date: 2016-12-12 Interventions: Biological: CYD Dengue Vaccine |
Not yet recruiting |
Study Name: Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects Condition: Dengue Fever Dengue Hemorrhagic Fever Date: 2016-12-12 Interventions: Biological: CYD Dengue Vaccine |
Not yet recruiting |
Study Name: Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE) Condition: Yellow Fever Date: 2016-12-07 Interventions: Biological: Stamaril, Sanofi Pasteur |
Recruiting |
Study Name: Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix® Condition: Dengue Fever Dengue Hemorrhagic Fever Human Papillomavirus Date: 2016-11-29 Interventions: Biological: CYD Dengue Vaccine |
Recruiting |
Study Name: Understanding Excretion and Infectivity of Zika Virus in Semen During and After Infection Condition: Zika Virus Date: 2016-11-17 Interventions: Other: Semen analysis and semen PCR for Zika virus Every two weeks subjects provide a semen sample which |
Recruiting |
Study Name: A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects. Condition: Zika Virus Infection Date: 2016-11-10 Interventions: Biological: IXIARO An inactiva |
Enrolling by invitation |
Study Name: Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine Condition: Dengue Fever Dengue Hemorrhagic Fever Date: 2016-10-27 |
Recruiting |
Study Name: Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero Condition: Microcephaly Mental Retardation Date: 2016-10-20 Interventions: Other: Symptomatic pregnant women with positive RT-PCR ZIKV in serum or urine, or a positive serologic test specific for ZIKV |